Skip to content

Telavancin

Vibativ (telavancin) is a small molecule pharmaceutical. Telavancin was first approved as Vibativ on 2009-09-11. It is used to treat bacterial infections, infectious skin diseases, pneumonia, staphylococcal infections, and streptococcal infections in the USA. Vibativ's patents are valid until 2027-01-01 (FDA).
Trade Name Vibativ
Common Name Telavancin
Indication bacterial infections, infectious skin diseases, pneumonia, staphylococcal infections, streptococcal infections
Drug Class Vancomycin-related compounds
Telavancin
Get full access now